Opendata, web and dolomites

PRECODE SIGNED

PancREatic Cancer OrganoiDs rEsearch Network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PRECODE project word cloud

Explore the words cloud of the PRECODE project. It provides you a very rough idea of what is the project "PRECODE" about.

interdisciplinary    investigation    professional    network    goes    central    reduce    training    small    biology    sources    minimal    education    capacitation    throughput    organization    esrs    isolated    organs    learning    sweden    clinical    therapy    disease    deduct    molecular    competences    drugs    organoid    metabolomics    doctorate    union    material    innovation    experiments    shared    thereof    tool    terrible    variety    creative    innovative    train    cultivate    patient    germany    groups    edge    earn    cutting    time    technologies    excellence    career    organoids    generation    firmly    perfect    viewed    fit    establishing    advocate    italy    combination    animal    international    pancreatic    intersectorial    medicine    3r    micro    cancer    secondments    fulfils    glove    workshops    precode    drug    precision    15    mission    beneficiaries    group    vitro    recapitulate    consists    techniques    goals    manipulate    function    sequencing    connect   

Project "PRECODE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITATSKLINIKUM ERLANGEN 

Organization address
address: MAXIMILIANSPLATZ 2
city: ERLANGEN
postcode: 91054
website: www.uk-erlangen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 3˙992˙891 €
 EC max contribution 3˙992˙891 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2023-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITATSKLINIKUM ERLANGEN DE (ERLANGEN) coordinator 252˙788.00
2    ASTRAZENECA UK LIMITED UK (CAMBRIDGE) participant 303˙172.00
3    UNIVERSITY OF GLASGOW UK (GLASGOW) participant 303˙172.00
4    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 281˙982.00
5    UMEA UNIVERSITET SE (UMEA) participant 281˙982.00
6    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 274˙684.00
7    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 265˙619.00
8    MIMETAS BV NL (Leiden) participant 265˙619.00
9    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 265˙619.00
10    UNIVERSITA DEGLI STUDI DI VERONA IT (VERONA) participant 261˙499.00
11    CELLPHENOMICS GMBH DE (BERLIN) participant 252˙788.00
12    FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG DE (ERLANGEN) participant 252˙788.00
13    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) participant 252˙788.00
14    UNIVERSIDAD DE NAVARRA ES (PAMPLONA) participant 250˙904.00
15    GDANSKI UNIWERSYTET MEDYCZNY PL (GDANSK) participant 227˙478.00

Map

 Project objective

The PRECODE Network (PancREatic Cancer OrganoiDs rEsearch) central mission is to establish pancreatic organoid research firmly in the European Union, by training the next generation of creative and innovative researchers in pancreatic cancer. This will be done through a shared doctorate program of excellence that fulfils the three “I”: international, interdisciplinary and intersectorial. Organoids can be viewed as small micro-organs which can recapitulate the organization and the function thereof. As micro-organs organoids can be used to reduce animal experiments and help to reach 3R goals. Organoids from pancreatic cancer will help us to learn which drugs might help in the therapy of this terrible disease. They can be isolated from a variety of clinical sources with minimal material needed. This makes them a perfect tool for precision medicine. Sequencing, metabolomics and high throughput in vitro experiments to deduct the best possible drug combination fit hand in glove with this approach. Training of ESRs will be achieved by e-learning, workshops and secondments. They will earn to cultivate and manipulate organoids as well as cutting edge molecular biology techniques. Therefore our work group consists of 15 beneficiaries and 7 partner organization (including three patient advocate groups from Sweden, Italy and Germany) to develop those technologies and to train ESRs in their application. PRECODE will therefore connect the concepts of investigation, education and innovation establishing a capacitation for the ESRs that goes beyond the state of the art and that will allow them to improve their competences and their professional career at the same time that we advance towards innovation in the field of pancreatic cancer research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRECODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PRECODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

MLFPM2018 (2019)

Machine Learning Frontiers in Precision Medicine

Read More